NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Wednesday that its fourth quarter revenues fell 23 percent year over year, largely due to a drop in sample accessions compared to same quarter last year.

For the three months ended Dec. 31, the company reported that its Q4 revenues fell to $995,226, compared to $1.3 million for Q4 2016. This included $61,000 from development services testing and $935,000 from commercial tests.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.

May
01
Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

May
15
Sponsored by
Tecan

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.